Literature DB >> 19561596

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma.

Terri A Addona1, Susan E Abbatiello, Birgit Schilling, Steven J Skates, D R Mani, David M Bunk, Clifford H Spiegelman, Lisa J Zimmerman, Amy-Joan L Ham, Hasmik Keshishian, Steven C Hall, Simon Allen, Ronald K Blackman, Christoph H Borchers, Charles Buck, Helene L Cardasis, Michael P Cusack, Nathan G Dodder, Bradford W Gibson, Jason M Held, Tara Hiltke, Angela Jackson, Eric B Johansen, Christopher R Kinsinger, Jing Li, Mehdi Mesri, Thomas A Neubert, Richard K Niles, Trenton C Pulsipher, David Ransohoff, Henry Rodriguez, Paul A Rudnick, Derek Smith, David L Tabb, Tony J Tegeler, Asokan M Variyath, Lorenzo J Vega-Montoto, Asa Wahlander, Sofia Waldemarson, Mu Wang, Jeffrey R Whiteaker, Lei Zhao, N Leigh Anderson, Susan J Fisher, Daniel C Liebler, Amanda G Paulovich, Fred E Regnier, Paul Tempst, Steven A Carr.   

Abstract

Verification of candidate biomarkers relies upon specific, quantitative assays optimized for selective detection of target proteins, and is increasingly viewed as a critical step in the discovery pipeline that bridges unbiased biomarker discovery to preclinical validation. Although individual laboratories have demonstrated that multiple reaction monitoring (MRM) coupled with isotope dilution mass spectrometry can quantify candidate protein biomarkers in plasma, reproducibility and transferability of these assays between laboratories have not been demonstrated. We describe a multilaboratory study to assess reproducibility, recovery, linear dynamic range and limits of detection and quantification of multiplexed, MRM-based assays, conducted by NCI-CPTAC. Using common materials and standardized protocols, we demonstrate that these assays can be highly reproducible within and across laboratories and instrument platforms, and are sensitive to low mug/ml protein concentrations in unfractionated plasma. We provide data and benchmarks against which individual laboratories can compare their performance and evaluate new technologies for biomarker verification in plasma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19561596      PMCID: PMC2855883          DOI: 10.1038/nbt.1546

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  25 in total

1.  Absolute quantification of the G protein-coupled receptor rhodopsin by LC/MS/MS using proteolysis product peptides and synthetic peptide standards.

Authors:  David R Barnidge; Edward A Dratz; Therese Martin; Leo E Bonilla; Liam B Moran; Arnold Lindall
Journal:  Anal Chem       Date:  2003-02-01       Impact factor: 6.986

2.  The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline.

Authors:  Amanda G Paulovich; Jeffrey R Whiteaker; Andrew N Hoofnagle; Pei Wang
Journal:  Proteomics Clin Appl       Date:  2008-10-01       Impact factor: 3.494

3.  The human plasma proteome: a nonredundant list developed by combination of four separate sources.

Authors:  N Leigh Anderson; Malu Polanski; Rembert Pieper; Tina Gatlin; Radhakrishna S Tirumalai; Thomas P Conrads; Timothy D Veenstra; Joshua N Adkins; Joel G Pounds; Richard Fagan; Anna Lobley
Journal:  Mol Cell Proteomics       Date:  2004-01-12       Impact factor: 5.911

4.  Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database.

Authors:  Gilbert S Omenn; David J States; Marcin Adamski; Thomas W Blackwell; Rajasree Menon; Henning Hermjakob; Rolf Apweiler; Brian B Haab; Richard J Simpson; James S Eddes; Eugene A Kapp; Robert L Moritz; Daniel W Chan; Alex J Rai; Arie Admon; Ruedi Aebersold; Jimmy Eng; William S Hancock; Stanley A Hefta; Helmut Meyer; Young-Ki Paik; Jong-Shin Yoo; Peipei Ping; Joel Pounds; Joshua Adkins; Xiaohong Qian; Rong Wang; Valerie Wasinger; Chi Yue Wu; Xiaohang Zhao; Rong Zeng; Alexander Archakov; Akira Tsugita; Ilan Beer; Akhilesh Pandey; Michael Pisano; Philip Andrews; Harald Tammen; David W Speicher; Samir M Hanash
Journal:  Proteomics       Date:  2005-08       Impact factor: 3.984

Review 5.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

6.  Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma.

Authors:  Michael A Kuzyk; Derek Smith; Juncong Yang; Tyra J Cross; Angela M Jackson; Darryl B Hardie; N Leigh Anderson; Christoph H Borchers
Journal:  Mol Cell Proteomics       Date:  2009-05-01       Impact factor: 5.911

7.  Performance characteristics of seven automated CA 15-3 assays.

Authors:  Patricia R Slev; Mindy L Rawlins; William L Roberts
Journal:  Am J Clin Pathol       Date:  2006-05       Impact factor: 2.493

8.  Screening newborns for inborn errors of metabolism by tandem mass spectrometry.

Authors:  Bridget Wilcken; Veronica Wiley; Judith Hammond; Kevin Carpenter
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

9.  Quantification of NTproBNP in rat serum using immunoprecipitation and LC/MS/MS: a biomarker of drug-induced cardiac hypertrophy.

Authors:  Michael Berna; Lee Ott; Steve Engle; David Watson; Philip Solter; Bradley Ackermann
Journal:  Anal Chem       Date:  2008-01-08       Impact factor: 6.986

10.  Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry.

Authors:  Ralf Labugger; Jeremy A Simpson; Michelle Quick; Heather A Brown; Christine E Collier; Irina Neverova; Jennifer E Van Eyk
Journal:  Clin Chem       Date:  2003-06       Impact factor: 8.327

View more
  406 in total

1.  Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.

Authors:  Jason M Held; David J Britton; Gary K Scott; Elbert L Lee; Birgit Schilling; Michael A Baldwin; Bradford W Gibson; Christopher C Benz
Journal:  Mol Cancer Res       Date:  2012-06-05       Impact factor: 5.852

2.  Computational analysis of unassigned high-quality MS/MS spectra in proteomic data sets.

Authors:  Kang Ning; Damian Fermin; Alexey I Nesvizhskii
Journal:  Proteomics       Date:  2010-07       Impact factor: 3.984

3.  Targeted ion parking for the quantitation of biotherapeutic proteins: concepts and preliminary data.

Authors:  J Larry Campbell; J C Yves Le Blanc
Journal:  J Am Soc Mass Spectrom       Date:  2010-08-27       Impact factor: 3.109

4.  Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry.

Authors:  Sean A Agger; Luke C Marney; Andrew N Hoofnagle
Journal:  Clin Chem       Date:  2010-10-05       Impact factor: 8.327

5.  Verification of male infertility biomarkers in seminal plasma by multiplex selected reaction monitoring assay.

Authors:  Andrei P Drabovich; Keith Jarvi; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2011-09-20       Impact factor: 5.911

6.  Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma.

Authors:  Eric Kuhn; Jeffrey R Whiteaker; D R Mani; Angela M Jackson; Lei Zhao; Matthew E Pope; Derek Smith; Keith D Rivera; N Leigh Anderson; Steven J Skates; Terry W Pearson; Amanda G Paulovich; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

7.  Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam Principles).

Authors:  Christopher R Kinsinger; James Apffel; Mark Baker; Xiaopeng Bian; Christoph H Borchers; Ralph Bradshaw; Mi-Youn Brusniak; Daniel W Chan; Eric W Deutsch; Bruno Domon; Jeff Gorman; Rudolf Grimm; William Hancock; Henning Hermjakob; David Horn; Christie Hunter; Patrik Kolar; Hans-Joachim Kraus; Hanno Langen; Rune Linding; Robert L Moritz; Gilbert S Omenn; Ron Orlando; Akhilesh Pandey; Peipei Ping; Amir Rahbar; Robert Rivers; Sean L Seymour; Richard J Simpson; Douglas Slotta; Richard D Smith; Stephen E Stein; David L Tabb; Danilo Tagle; John R Yates; Henry Rodriguez
Journal:  Mol Cell Proteomics       Date:  2011-11-03       Impact factor: 5.911

8.  Targeted data extraction of the MS/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis.

Authors:  Ludovic C Gillet; Pedro Navarro; Stephen Tate; Hannes Röst; Nathalie Selevsek; Lukas Reiter; Ron Bonner; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2012-01-18       Impact factor: 5.911

Review 9.  A Review on Quantitative Multiplexed Proteomics.

Authors:  Nishant Pappireddi; Lance Martin; Martin Wühr
Journal:  Chembiochem       Date:  2019-04-18       Impact factor: 3.164

Review 10.  Heterogeneity and specialized functions of translation machinery: from genes to organisms.

Authors:  Naomi R Genuth; Maria Barna
Journal:  Nat Rev Genet       Date:  2018-07       Impact factor: 53.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.